Showing results (11-20 of 350) with videos related to
Sort By:
Pageof 35
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Where do we stand on neuroprotection? Where do we go from here?I ShoulsonNeurology|August 1, 1975
Caffeine and the antiparkinsonian response to levodopa or piribedilI Shoulson, T ChaseAnnals of Neurology|April 1, 1983
Familial paroxysmal dystonic choreoathetosis and response to alternate-day oxazepam therapyR Kurlan, I ShoulsonThe American Journal of Psychiatry|June 1, 1983
Psychiatric syndromes in Huntington's diseaseE D Caine, I ShoulsonNeurology|May 20, 1998
Levodopa therapy: consequences of the nonphysiologic replacement of dopamineT N ChaseDrugs|March 4, 1998
The significance of continuous dopaminergic stimulation in the treatment of Parkinson's diseaseT N ChaseMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987
Hereditary myoclonus and chorea: the spectrum of hereditary nonprogressive hyperkinetic movement disordersR Kurlan, J Behr, I ShoulsonNeurology|August 1, 1976
Studies with bromocriptine: III. Concomitant administration of caffeine to patients with idiopathic parkinsonismR Kartzinel, I Shoulson, D B CalneNeurology|June 1, 1976
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonismR Kartzinel, I Shoulson, D B CalnePageof 35